Often we get so busy working with patients that we forget about the business of diabetes. David Kliff, Publisher, Diabetes investor brings us information on Making the case for insulin – the Battle for type 2 patients isn’t limited to oral agents and GLP-1’s. He lays it on the line …

The next president of the United States will be trying to pass legislation that will effect your medical costs and also your patients costs. This week item #4 tries to explain each of their approaches to changing our healthcare system, and since it seems all politicians think that prescription benefits …

Researchers at the University of North Carolina at Chapel Hill School of Medicine have transformed cells from human skin into cells that produce insulin, the same hormone used to treat diabetes.

Regular moderate exercise helps people with diabetes to reduce fat in their livers, in turn potentially preventing liver failure and heart disease, said U.S. researchers.

Over the 52-week period of this study, A1C levels decreased comparably in the two treatment groups. Plus there was less hypoglycemia and weight loss with the inhaled insulin and weight gain with the injectable insulin.

Democratic presidential candidate Barack Obama’s health care plan would cost too much and create more regulation, while Republican John McCain’s plan would leave 60 million Americans without health insurance and reduce coverage, experts said last week.

For patients with type 1 or type 2 diabetes, pre-prandial glucose levels are generally more closely associated with long-term HbA1c levels than post-prandial glucose levels, according to a new study.

MannKind Corporation and Pfizer announced that MannKind will transition certain Exubera patients with a continuing need for inhaled insulin to MannKind’s inhaled insulin product, Technosphere(R) Insulin. Technosphere Insulin is an investigational product that has recently completed Phase 3 clinical trials.

A group of sedentary and overweight older people placed on a four-month exercise program not only became more fit, but burned off more fat, compared to older sedentary people who were placed on a diet but did not exercise.

Lowering blood pressure and intensive glucose control are additive in reducing the risk of cardiovascular mortality and all-cause mortality in people with type 2 diabetes, new results from the Action in Diabetes and Vascular Disease (ADVANCE) trial show.